<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="same sites. The flares had begun within hours of ingesting" exact="nicardipine" post="hydrochloride, amlodipine besilate, candesartan cilexetil and atenolol for the"/>
 <result pre="The flares had begun within hours of ingesting nicardipine hydrochloride," exact="amlodipine" post="besilate, candesartan cilexetil and atenolol for the first time"/>
 <result pre="had begun within hours of ingesting nicardipine hydrochloride, amlodipine besilate," exact="candesartan" post="cilexetil and atenolol for the first time despite showing"/>
 <result pre="hours of ingesting nicardipine hydrochloride, amlodipine besilate, candesartan cilexetil and" exact="atenolol" post="for the first time despite showing a low level"/>
 <result pre="fixed drug eruption Parapsoriasis en plaque Pegylated interferon α-2b plus" exact="ribavirin" post="fig-count: table-count: ref-count: page-count: Introduction Although it has been"/>
 <result pre="alleviate sustained virologic responses [4], pegylated IFN (PEG-IFN) concomitant with" exact="ribavirin" post="is used in patients with HCV genotype 1b [5,"/>
 <result pre="cascade [7, 8], adverse effects of treatment with IFN plus" exact="ribavirin" post="are attributed to IFN. Accordingly, since IFN can stimulate"/>
 <result pre="hypertension and over several years had been sequentially treated with" exact="nicardipine" post="hydrochloride, amlodipine besilate, and candesartan cilexetil. Because her blood"/>
 <result pre="over several years had been sequentially treated with nicardipine hydrochloride," exact="amlodipine" post="besilate, and candesartan cilexetil. Because her blood pressure control"/>
 <result pre="had been sequentially treated with nicardipine hydrochloride, amlodipine besilate, and" exact="candesartan" post="cilexetil. Because her blood pressure control was poor, her"/>
 <result pre="she had been started on combination therapy of PEG-IFNα-2b plus" exact="ribavirin" post="administered subcutaneously to treat progressive liver disease, but treatment"/>
 <result pre="did not ameliorate the skin lesions. Meanwhile, following PEG-IFNα-2b plus" exact="ribavirin" post="therapy, her ALT level decreased but remained above normal,"/>
 <result pre="decreased but remained above normal, whereas discontinuation of PEG-IFNα-2b plus" exact="ribavirin" post="resulted in an increase in the HCV RNA level."/>
 <result pre="HCV RNA level. Because the patient refused further PEG-IFN-α-2b plus" exact="ribavirin" post="therapy complaining of fatigue and headache, she stopped taking"/>
 <result pre="of fatigue and headache, she stopped taking all medications except" exact="ursodeoxycholic acid," post="900 mg daily. Gradual improvement in skin lesions was"/>
 <result pre="possibility that her skin lesions had been a reaction to" exact="candesartan" post="cilexetil, she was asked to avoid this medicine, and"/>
 <result pre="candesartan cilexetil, she was asked to avoid this medicine, and" exact="amlodipine" post="besilate was re-administered to control her hypertension. However, a"/>
 <result pre="to control her hypertension. However, a few days later on" exact="amlodipine" post="besilate, her skin lesions worsened again (Fig. 3a), so"/>
 <result pre="amlodipine besilate, her skin lesions worsened again (Fig. 3a), so" exact="amlodipine" post="besilate was discontinued. By 8 weeks later, in August"/>
 <result pre="pressure was high (165/110), the patient consented to start oral" exact="atenolol" post="daily. Thereafter, the patient's course was complicated by additional"/>
 <result pre="recurrences that appeared within a month of starting treatment with" exact="atenolol" post="gradually subsided, HCV RNA levels increased. Thus, there was"/>
 <result pre="before the start of taking atenolol, she consented to retake" exact="amlodipine" post="besilate. Within 24 h, a small oval erythematous plaque"/>
 <result pre="levels increased, but her blood pressure control was poor, so" exact="candesartan" post="cilexetil was added again in June 2012. Oral challenge"/>
 <result pre="was added again in June 2012. Oral challenge tests of" exact="atenolol" post="were performed with no observed recurrences in January 2013."/>
 <result pre="responses. A report of multiple FDE triggered by IFN +" exact="ribavirin" post="in a patient with HCV infection supports this argument"/>
 <result pre="Baker [13] reported a case of chronic FDE caused by" exact="acetaminophen" post="that simulated parapsoriasis en plaque. Interestingly, the lesions recurred"/>
 <result pre="hepatitis infection be complicated by malignant lymphoma?Lancet199511346(8987)14267 4ReddyKRBourlièreMSulkowskiMOmataMZeuzemSFeldJJet al.Ledipasvir and" exact="sofosbuvir" post="in patients with genotype 1 hepatitis C virus infection"/>
 <result pre="inhibition of intracellular hepatitis C virus replication by combination of" exact="ribavirin" post="and interferon- αJ Infect Dis20044189(7)11293915031779 7GuttermanJUCytokine therapeutics: lessons from"/>
 <result pre="�?, ALT; ▲, HCV RNA; ↓, oral challenge test with" exact="amlodipine" post="besilate; ↡, oral challenge test with atenolol. Fig. 2"/>
 <result pre="the neck and trunk resembling parapsoriasis. Fig. 3 a Taking" exact="amlodipine" post="besilate in May 2011. b Erythematous plaque reappearance at"/>
 <result pre="reappearance at the previously affected site after clinical challenge with" exact="amlodipine" post="besilate. Table 1 Results of lymphocyte transformation tests with"/>
</results>
